By Hanna Vioque ( January 16, 2025, 6:33 PM GMT) -- Bausch & Lomb has defeated a generic drugmaker's challenge to an amended patent for its blockbuster eye drops, after European officials found that its use of a particular inactive ingredient wasn't obvious to other scientists in the field. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.